Literature DB >> 28567508

[Psoriasis capitis and seborrhoic eczema of scalp diseases].

M Sticherling1.   

Abstract

The scalp may be affected by various diseases with equally varying manifestations. Erythema and scaling is often accompanied by agonizing itch. Scalp psoriasis and seborrheic eczema represent the most frequent diseases, which can be differentiated into classical cases; however, overlap and similarities are seen. Sharply demarcated erythematosquamous plaques across the natural hairline in psoriasis are opposed to blurred dark-red erythema and yellowish, greasy scales in seborrheic eczema. Whereas with the latter diffuse alopecia may frequently be found, hair loss is rarely seen in psoriasis and may also be related to therapeutic agents. Treatment is based on acuity as well as extent of disease and individual life quality aspects of the patients. It is mainly based on topical corticosteroids, combined with vitamin D derivatives in psoriasis and antimycotic agents in seborrheic eczema. In severe cases and widespread psoriatic disease, systemic treatment may be necessary, including the classic agents methotrexate, fumarates and ciclosporin as well as biologicals. Systemic treatment of seborrheic eczema is rarely necessary and resides on corticosteroids, antimycotic agents and vitamin A derivatives. In addition, intensive counseling of patients on the necessity of consequent and long-term treatment as well as use of mild skin care products is mandatory.

Entities:  

Keywords:  Itch; Malassezia furfur; Scalp; Systemic therapy; Topical therapy

Mesh:

Substances:

Year:  2017        PMID: 28567508     DOI: 10.1007/s00105-017-3986-4

Source DB:  PubMed          Journal:  Hautarzt        ISSN: 0017-8470            Impact factor:   0.751


  34 in total

Review 1.  Hair and scalp dermatoscopy.

Authors:  Mariya Miteva; Antonella Tosti
Journal:  J Am Acad Dermatol       Date:  2012-03-08       Impact factor: 11.527

2.  Treating seborrheic dermatitis: review of mechanisms and therapeutic options.

Authors:  Neal Bhatia
Journal:  J Drugs Dermatol       Date:  2013-07-01       Impact factor: 2.114

3.  Dandruff, seborrheic dermatitis, and psoriasis drug products containing coal tar and menthol for over-the-counter human use; amendment to the monograph. Final rule.

Authors: 
Journal:  Fed Regist       Date:  2007-03-06

Review 4.  Topical antifungals for seborrhoeic dermatitis.

Authors:  Enembe O Okokon; Jos H Verbeek; Jani H Ruotsalainen; Olumuyiwa A Ojo; Victor Nyange Bakhoya
Journal:  Cochrane Database Syst Rev       Date:  2015-05-02

5.  Collapse of human scalp microbiome network in dandruff and seborrhoeic dermatitis.

Authors:  Taehun Park; Hye-Jin Kim; Nu Ri Myeong; Hyun Gee Lee; Ilyoung Kwack; Johnhwan Lee; Beom Joon Kim; Woo Jun Sul; Susun An
Journal:  Exp Dermatol       Date:  2017-04-11       Impact factor: 3.960

Review 6.  Skin diseases associated with Malassezia yeasts: facts and controversies.

Authors:  Georgios Gaitanis; Aristea Velegraki; Peter Mayser; Ioannis D Bassukas
Journal:  Clin Dermatol       Date:  2013 Jul-Aug       Impact factor: 3.541

Review 7.  Malassezia species in healthy skin and in dermatological conditions.

Authors:  Asja Prohic; Tamara Jovovic Sadikovic; Mersiha Krupalija-Fazlic; Suada Kuskunovic-Vlahovljak
Journal:  Int J Dermatol       Date:  2015-12-29       Impact factor: 2.736

Review 8.  [Allergic contact dermatitis of the scalp].

Authors:  L Koch; W Aberer
Journal:  Hautarzt       Date:  2017-06       Impact factor: 0.751

Review 9.  A practical guide to scalp disorders.

Authors:  Ramon Grimalt
Journal:  J Investig Dermatol Symp Proc       Date:  2007-12

10.  Histopathological Differential Diagnosis of Psoriasis and Seborrheic Dermatitis of the Scalp.

Authors:  Ji-Hye Park; Young Joon Park; Sue Kyoung Kim; Ji Eun Kwon; Hee Young Kang; Eun-So Lee; Jee Ho Choi; You Chan Kim
Journal:  Ann Dermatol       Date:  2016-07-26       Impact factor: 1.444

View more
  1 in total

Review 1.  [Pruritus of the scalp : Simply pulling out your hair?]

Authors:  M Beigi; E Weisshaar
Journal:  Hautarzt       Date:  2017-06       Impact factor: 0.751

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.